Determining whether someone is a suitable tumor ablation candidate involves far more than looking at a single scan. Interventional radiologists, oncologists, and surgeons typically review imaging, tumor biology, and a patient's overall health together before recommending a minimally invasive ablation approach over surgery, radiation, or systemic therapy. Understanding the general factors that go into this evaluation can help patients have more informed conversations with their care teams.
What Tumor Characteristics Matter Most?
Tumor size, number, and location are commonly cited as the first filters in candidacy discussions. Smaller, well-defined tumors are generally easier to treat completely with thermal or other ablative energy because the ablation zone can more reliably cover the tumor with a margin of surrounding tissue. Larger tumors may still be considered, sometimes with staged treatments or combination therapy, though outcomes and technique vary by clinical judgment.
Location also matters significantly. Tumors near major blood vessels, bile ducts, bowel, or the diaphragm can pose additional technical challenges because heat or cold from ablation may affect nearby structures, and blood flow near large vessels can carry heat away from the treatment zone. This does not automatically exclude a patient, but it often changes the technique, approach angle, or use of protective maneuvers during the procedure.
How Do Comorbidities Affect Ablation Eligibility?
A patient's broader health picture is weighed alongside the tumor itself. Conditions such as poor kidney function, uncontrolled bleeding disorders, active infection, or limited cardiopulmonary reserve can influence whether a patient is considered appropriate for a percutaneous or laparoscopic ablation procedure, and whether it is performed under sedation or general anesthesia. In many cases, patients who are not considered good candidates for major surgery due to comorbidities may still be appropriate for image-guided ablation, since it is generally less invasive than open resection.
Liver function, in the case of liver tumors, and overall performance status are also commonly reviewed. A qualified physician determines suitability on an individual basis, taking into account how a patient is likely to tolerate the procedure and recover afterward.
Why Is a Multidisciplinary Tumor Board Involved?
Many cancer centers route ablation candidacy decisions through a multidisciplinary tumor board, where interventional radiologists, medical oncologists, surgical oncologists, radiation oncologists, and pathologists discuss a case together. This collaborative model exists because ablation is one of several treatment options for many tumor types, alongside surgical resection, radiation therapy, and systemic therapies, and the optimal sequence or combination often depends on factors that span multiple specialties.
A tumor board discussion typically reviews imaging, biopsy results, prior treatments, and the patient's stated goals of care. This process is intended to align the treatment plan with the specific clinical situation rather than applying a one-size-fits-all approach.
What Role Does the Ablation Device Play?
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
What happens if a tumor board decides ablation is not appropriate?
If ablation is not recommended, the tumor board typically discusses alternative options such as surgical resection, radiation therapy, systemic treatment, or a combination of therapies. The final recommendation depends on the specific tumor characteristics and the patient's overall clinical situation.